Buratti E - Search Results

1

Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity.

Zhang YJ, Xu YF, Cook C, Gendron TF, Roettges P, Link CD, Lin WL, Tong J, Castanedes-Casey M, Ash P, Gass J, Rangachari V, Buratti E, Baralle F, Golde TE, Dickson DW, Petrucelli L. Zhang YJ, et al. Among authors: buratti e. Proc Natl Acad Sci U S A. 2009 May 5;106(18):7607-12. doi: 10.1073/pnas.0900688106. Epub 2009 Apr 21. Proc Natl Acad Sci U S A. 2009. PMID: 19383787 Free PMC article.

2

Localization of the different hepatitis C virus core gene products expressed in COS-1 cells.

Buratti E, Baralle FE, Tisminetzky SG. Buratti E, et al. Cell Mol Biol (Noisy-le-grand). 1998 May;44(3):505-12. Cell Mol Biol (Noisy-le-grand). 1998. PMID: 9620447

3

Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9.

Buratti E, Baralle FE. Buratti E, et al. J Biol Chem. 2001 Sep 28;276(39):36337-43. doi: 10.1074/jbc.M104236200. Epub 2001 Jul 24. J Biol Chem. 2001. PMID: 11470789 Free article.

4

Can a 'patch' in a skipped exon make the pre-mRNA splicing machine run better?

Buratti E, Baralle FE, Pagani F. Buratti E, et al. Trends Mol Med. 2003 Jun;9(6):229-32; discussion 233-4. doi: 10.1016/s1471-4914(03)00072-8. Trends Mol Med. 2003. PMID: 12829008

5

Nuclear factor TDP-43 binds to the polymorphic TG repeats in CFTR intron 8 and causes skipping of exon 9: a functional link with disease penetrance.

Buratti E, Brindisi A, Pagani F, Baralle FE. Buratti E, et al. Am J Hum Genet. 2004 Jun;74(6):1322-5. doi: 10.1086/420978. Am J Hum Genet. 2004. PMID: 15195661 Free PMC article. No abstract available.

6

Influence of RNA secondary structure on the pre-mRNA splicing process.

Buratti E, Baralle FE. Buratti E, et al. Mol Cell Biol. 2004 Dec;24(24):10505-14. doi: 10.1128/MCB.24.24.10505-10514.2004. Mol Cell Biol. 2004. PMID: 15572659 Free PMC article. Review. No abstract available.

7

Another step forward for SELEXive splicing.

Buratti E, Baralle FE. Buratti E, et al. Trends Mol Med. 2005 Jan;11(1):5-9. doi: 10.1016/j.molmed.2004.11.007. Trends Mol Med. 2005. PMID: 15649816 Review.

8

Human, Drosophila, and C.elegans TDP43: nucleic acid binding properties and splicing regulatory function.

Ayala YM, Pantano S, D'Ambrogio A, Buratti E, Brindisi A, Marchetti C, Romano M, Baralle FE. Ayala YM, et al. Among authors: buratti e. J Mol Biol. 2005 May 6;348(3):575-88. doi: 10.1016/j.jmb.2005.02.038. J Mol Biol. 2005. PMID: 15826655

9

TDP-43 binds heterogeneous nuclear ribonucleoprotein A/B through its C-terminal tail: an important region for the inhibition of cystic fibrosis transmembrane conductance regulator exon 9 splicing.

Buratti E, Brindisi A, Giombi M, Tisminetzky S, Ayala YM, Baralle FE. Buratti E, et al. J Biol Chem. 2005 Nov 11;280(45):37572-84. doi: 10.1074/jbc.M505557200. Epub 2005 Sep 12. J Biol Chem. 2005. PMID: 16157593 Free article.

10

Depletion of TDP 43 overrides the need for exonic and intronic splicing enhancers in the human apoA-II gene.

Mercado PA, Ayala YM, Romano M, Buratti E, Baralle FE. Mercado PA, et al. Among authors: buratti e. Nucleic Acids Res. 2005 Oct 27;33(18):6000-10. doi: 10.1093/nar/gki897. Print 2005. Nucleic Acids Res. 2005. PMID: 16254078 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

252 results

Search Page